Retour sur lavenir.net
   VASTNED 29.500 € (+0,34 %)     WDP 22.140 € (-2,64 %)     D'IETEREN GROUP 174.800 € (+0,92 %)     GBL 78.450 € (+0,58 %)     KINEPOLIS GROUP 38.100 € (0,00 %)     KBC ANCORA 87.500 € (+1,86 %)     GIMV 44.750 € (+0,45 %)     ARGENX SE 804.400 € (+0,93 %)     LOTUS BAKERIES 10 720.000 € (+0,37 %)     MELEXIS 70.650 € (-2,35 %)     UCB 246.000 € (+1,23 %)     ONTEX GROUP 2.190 € (+0,23 %)     DECEUNINCK 2.135 € (-2,95 %)     SHURGARD 25.550 € (+0,99 %)     AGFA-GEVAERT 0.371 € (+0,27 %)     CIE BOIS SAUVAGE 301.000 € (+0,33 %)     IMMOBEL 21.600 € (-0,46 %)     AGEAS 71.650 € (-0,21 %)     COLRUYT 38.000 € (-0,21 %)     AEDIFICA 70.050 € (-0,36 %)     ECONOCOM GROUP 1.410 € (-3,42 %)     ELIA GROUP 138.500 € (-0,22 %)     EXMAR 11.500 € (0,00 %)     ASCENCIO 52.300 € (0,00 %)     CMB.TECH 13.860 € (+0,87 %)     TUBIZE-FIN 209.800 € (+1,25 %)     EVS 27.050 € (+0,56 %)     SIPEF 93.100 € (+0,54 %)     BANQUP GROUP 2.100 € (0,00 %)     BEKAERT 42.050 € (+1,08 %)     PROXIMUS 6.115 € (+0,33 %)     KBC 122.400 € (+1,32 %)     NYXOAH 1.240 € (-4,62 %)     ENERGYVISION 14.900 € (+0,40 %)     JENSEN-GROUP 84.400 € (+0,48 %)     VAN DE VELDE 29.800 € (-0,67 %)     TINC 11.300 € (+0,36 %)     BREDERODE 102.400 € (+0,20 %)     FAGRON 23.250 € (+0,22 %)     VGP 84.400 € (+1,44 %)     DEME GROUP 168.000 € (+0,12 %)     UMICORE 20.280 € (+3,42 %)     SYENSQO 71.050 € (+1,57 %)     CFE 12.100 € (+1,68 %)     SOFINA 238.000 € (+1,45 %)     RETAIL ESTATES 65.900 € (+1,23 %)     BARCO 7.950 € (-0,56 %)     AZELIS GROUP 10.620 € (+0,28 %)     IBA 16.420 € (+2,11 %)     ONWARD MEDICAL 2.405 € (0,00 %)     RECTICEL 11.900 € (-0,17 %)     TESSENDERLO 20.800 € (+0,73 %)     ACKERMANS V.HAAREN 265.800 € (-0,08 %)     FLUXYS BELGIUM D 20.000 € (0,00 %)     CARE PROPERTY INV. 12.680 € (+0,48 %)     TITAN S.A. 50.450 € (+2,50 %)     CAMPINE 207.000 € (-1,43 %)     AB INBEV 71.640 € (+1,16 %)     HOME INVEST BE. 19.880 € (+0,81 %)     SOLVAY 26.420 € (-0,30 %)  
   ADVICENNE 1.648 € (+4,30 %)     KPN KON 4.101 € (-0,92 %)     ASM INTERNATIONAL 859.400 € (-1,63 %)     BNP PARIBAS ACT.A 105.920 € (+2,08 %)     SCHNEIDER ELECTRIC 268.050 € (+1,00 %)     VALEO 13.730 € (-2,31 %)     SHELL PLC 38.775 € (-1,07 %)     ING GROEP N.V. 28.950 € (+1,49 %)     ASML HOLDING 1 563.000 € (-1,03 %)     ABIVAX 112.800 € (-1,48 %)     COVIVIO 53.100 € (+0,38 %)     LEGRAND 134.300 € (-0,48 %)     2CRSI 27.580 € (+4,08 %)     DASSAULT AVIATION 299.200 € (-1,77 %)     ALTHEORA 0.400 € (+12,99 %)     TKH GROUP 42.980 € (-0,74 %)     HEINEKEN 76.420 € (+0,92 %)     ARCADIS 41.400 € (+5,08 %)     CROSSJECT 1.504 € (-2,21 %)     RISING STONE 50.000 € (+0,50 %)     EUROPLASMA 0.001 € (0,00 %)     S.E.B. 52.700 € (-4,70 %)     AKZO NOBEL 57.860 € (+2,81 %)     AYVENS 11.620 € (+0,17 %)     SAINT GOBAIN 74.160 € (+1,81 %)     BOUYGUES 47.540 € (-0,61 %)     BAM GROEP KON 11.000 € (-2,05 %)     FDJ UNITED 22.410 € (-0,22 %)     UBISOFT ENTERTAIN 4.825 € (+2,12 %)     LVMH 461.700 € (+1,80 %)     UNIFY GROUP 1.800 € (-2,91 %)     BROADPEAK 2.380 € (-9,51 %)     AALBERTS NV 41.660 € (+0,43 %)     DSM FIRMENICH AG 81.400 € (+0,94 %)     CA TOULOUSE 31 CCI 119.840 € (-1,72 %)     L'OREAL 374.700 € (+1,59 %)     STMICROELECTRONICS 46.765 € (-2,46 %)     BENETEAU 6.110 € (+1,50 %)     SARTORIUS STED BIO 167.300 € (+2,01 %)     KERING 242.300 € (+1,47 %)     PROSUS 36.755 € (+0,82 %)     CAPITAL B 0.477 € (+1,25 %)     EURAZEO 47.680 € (+5,91 %)     WORLDLINE 9.688 € (+2,67 %)     BE SEMICONDUCTOR 227.000 € (-1,26 %)     ATOS GROUP 30.080 € (+4,74 %)     TECHNIP ENERGIES 34.360 € (+1,06 %)     SIGNIFY NV 14.570 € (-8,82 %)     HEINEKEN HOLDING 70.500 € (+0,86 %)     REXEL 37.630 € (+0,24 %)     ACCOR 46.310 € (+2,07 %)     ADYEN 801.000 € (+0,70 %)     ASR NEDERLAND 69.960 € (+0,32 %)     CEGEDIM 10.100 € (-1,94 %)     SES 7.010 € (-3,11 %)     VERALLIA 18.660 € (-0,21 %)     EDENRED 26.410 € (+0,99 %)     LAKEFRONT BIOTHER. 24.500 € (-1,13 %)     THALES 236.400 € (-0,80 %)     HAVAS 18.550 € (+1,37 %)  
News Réglementées
24/07/2026 12:40

Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India

EQS-News: Alcon / Key word(s): Agreement/Product Launch
Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India

24.07.2026 / 12:40 CET/CEST
The issuer is solely responsible for the content of this announcement.


  • Second Centre of Excellence expands Alcon and Aravind's partnership to strengthen Retina care training
  • Dedicated training hub will help expand access to advanced retina care

COIMBATORE, India, July 24, 2026 /PRNewswire/ -- Aravind Eye Care System and Alcon, Global Leader in Eye Care today announced the launch of the Aravind Alcon Global Centre of Excellence (CoE) for Vitreoretinal Surgery Training in Coimbatore. Building on the successful launch of the Global Cataract Centre of Excellence in 2024, the new Centre marks the second phase of Aravind & Alcon's Partnership to address one of the most critical gaps in global eye care – access to retina training. The dedicated Vitreoretinal Centre of Excellence will strengthen surgical capability by equipping ophthalmologists with advanced retina training and expanding access to quality eye care in underserved regions.

Mr. Rajkumar Narayanan, Senior Vice President, President Alcon International inaugurates the Aravind Alcon Global Centre of Excellence (CoE) for Vitreoretinal Surgery

While cataract care has scaled effectively, retina care remains limited due to a shortage of trained specialists, particularly across Africa, Latin America and parts of Asia. Established within Aravind Eye Care System, the Centre is designed as a global training hub that combines hands-on surgical training with scalable virtual education, focusing on practical surgical capability and long-term capacity building. The Centre also features a state-of-the-art wet laboratory for vitreoretinal training and will initially train approximately 60 participants annually, while also extending its reach through virtual fellowship programmes.

Speaking on the occasion, Mr. Raj Narayanan, Senior Vice President and President International, Alcon said, "For more than two decades, Alcon and Aravind have partnered to advance surgical education and help strengthen eye care around the world. The inauguration of this new Global Centre of Excellence in Retina marks an important step in our shared commitment to developing the next generation of eye care professionals through world-class training and capability building. We are proud to continue a partnership that is helping improve patient outcomes and expand access to high-quality eye care globally."

Dr. Narendran, Chief Medical Officer, Aravind Eye Care Hospital, Coimbatore, said: "At Aravind Eye Care System, training has been central to our mission of eliminating needless blindness from the beginning. For more than two decades, our partnership with Alcon has helped us translate this commitment into world-class surgical education. We are proud that Aravind Eye Hospital, Coimbatore, is now home to India's first Global Center of Excellence in Retina. This comes at a critical time, as retinal disease is an increasingly common cause of vision loss in India and worldwide, and the need for skilled retinal surgeons continues to grow. The center provides the next generation of ophthalmologists with a structured, hands-on pathway to master complex procedures with precision and confidence. Together with Alcon, we look forward to strengthening eye care, improve patient outcomes, and expand access to quality treatment for all who need it."

Aravind Eye Care System is recognised globally for delivering high-quality eye care alongside world-class medical education and knowledge transfer. The new Centre will advance vitreoretinal training by helping strengthen surgical capabilities and improve access to retina care across regions where specialist retina services remain scarce. By combining hands-on training with scalable virtual education, the initiative aims to build long-term healthcare capacity and support better patient outcomes worldwide.

About Alcon

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Connect with us on
Facebook | LinkedIn

 

Alcon Logo

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/aravind-eye-care-system-and-alcon-launch-global-centre-of-excellence-for-retina-training-in-coimbatore-india-302834074.html

rt.gif?NewsItemId=EN11646&Transmission_Id=202607240637PR_NEWS_EURO_ND__EN11646&DateId=20260724


24.07.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2371356  24.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière